| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 03/21/2013 | WO2013037333A1 6, 8- disubstituted purine compositions and their pharmaceutical and cosmetic use |
| 03/21/2013 | WO2012031138A3 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione |
| 03/21/2013 | US20130072506 6,8-disubstituted purine compositions |
| 03/21/2013 | US20130072504 Crystalline forms of a purine derivative |
| 03/20/2013 | CN102985423A Crystalline forms of a purine derivative |
| 03/19/2013 | US8399712 Pterostilbene cocrystals |
| 03/19/2013 | US8399490 Insecticides |
| 03/14/2013 | WO2012142029A3 Serms for the treatment of estrogen receptor-mediated disorders |
| 03/14/2013 | US20130066071 Carbanucleoside synthesis and novel intermediate compounds useful therein |
| 03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
| 03/13/2013 | CN102964347A 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 03/12/2013 | US8394808 HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes |
| 03/07/2013 | WO2013032939A1 Bicyclic agonists of gpr131 and uses thereof |
| 03/06/2013 | CN102958931A Process for the synthesis of carbonucleoside and intermediates for use therein |
| 03/06/2013 | CN102952136A 恩替卡韦及其制备方法 Entecavir and its preparation method |
| 03/06/2013 | CN102952135A Synthesis method for medicine entecavir for treating hepatitis B |
| 03/06/2013 | CN102046201B Inhibitor of analgesic tolerance |
| 03/06/2013 | CN101817833B DPP-IV inhibitor |
| 02/28/2013 | US20130053406 Therapeutic compounds and uses thereof |
| 02/28/2013 | US20130052678 Uracil-specific fluorescence detection reaction and method for examining dihydropyrimidine dehydrogenase deficiency |
| 02/28/2013 | US20130052280 Use of thebromine for lowering central blood pressure |
| 02/27/2013 | CN102942582A Preparation method of entecavir key intermediate |
| 02/27/2013 | CN102229608B Improved method for preparing entecavir |
| 02/26/2013 | US8383634 Methods of treatment using heteroaryl compounds and compositions thereof |
| 02/26/2013 | CA2534682C Capped pyrazinoylguanidine sodium channel blockers |
| 02/21/2013 | WO2013026025A1 Cyclohexyl azetidine derivatives as jak inhibitors |
| 02/21/2013 | WO2013025788A1 Tenofovir alafenamide hemifumarate |
| 02/21/2013 | US20130045942 N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof |
| 02/21/2013 | CA2845553A1 Tenofovir alafenamide hemifumarate |
| 02/20/2013 | EP2558466A2 Phosphonates with reduced toxicity for treatment of viral infections |
| 02/20/2013 | EP2558099A2 Kinase inhibitors |
| 02/20/2013 | CN102939291A Phosphonates with reduced toxicity for treatment of viral infections |
| 02/20/2013 | CN102936248A Method for preparing doxofylline |
| 02/19/2013 | US8378044 Living radical polymerization method using alcohol as catalyst |
| 02/14/2013 | WO2013023102A1 Inhibiting transient receptor potential ion channel trpa1 |
| 02/14/2013 | US20130040949 Type ii raf kinase inhibitors |
| 02/14/2013 | CA2844742A1 Kinase inhibitor polymorphs |
| 02/14/2013 | CA2843965A1 Inhibiting transient receptor potential ion channel trpa1 |
| 02/13/2013 | EP2555617A1 Novel hypoglycemic compounds |
| 02/13/2013 | CN102933585A CARBA-nucleoside synthesis and novel intermediate compounds useful therein |
| 02/13/2013 | CN102924455A Synthetic method of famciclovir intermediate |
| 02/13/2013 | CN102924454A Synthetic method of entecavir |
| 02/13/2013 | CN102924453A Process method for extracting theine from teas |
| 02/13/2013 | CN101914097B Technological method for extracting caffeine and tea polyphenol mixture from tea step by step |
| 02/12/2013 | US8372852 Purines as reverse transcriptase inhibitors |
| 02/07/2013 | US20130035342 Compound Suitable for the Treatment of Synucleopathies |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | US20130032788 Carbazole-based compound and organic light-emitting diode comprising the same |
| 02/06/2013 | EP2552916A1 Purine compounds used as cb2 agonists |
| 02/06/2013 | EP2552908A2 Heterocyclic compounds and their uses |
| 02/06/2013 | CN102918040A Purinone derivative |
| 02/06/2013 | CN101528743B Fused heterocyclic derivatives and methods of use |
| 02/05/2013 | CA2714085C Method of manufacture of 1,3-oxathiolane nucleosides |
| 02/05/2013 | CA2709176C Reverse transcriptase inhibitors |
| 01/31/2013 | US20130029982 Heterocyclic compounds and uses thereof |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
| 01/30/2013 | CN102906074A Fused imidazole derivative |
| 01/30/2013 | CN102070635B Preparation method for ganciclovir valine ester derivative |
| 01/30/2013 | CN101781300B Entecavir salt compound, preparation method and medicine application thereof |
| 01/29/2013 | US8362244 Method for producing nucleoside derivatives |
| 01/29/2013 | US8362025 Compositions useful for treating disorders related to TRPA1 |
| 01/29/2013 | US8362024 Purinyl derivatives and their use as potassium channel modulators |
| 01/29/2013 | CA2536553C Substituted 8-heteroaryl xanthines |
| 01/29/2013 | CA2524778C Xanthine derivatives as a2b adenosine receptor antagonists |
| 01/24/2013 | WO2013013052A1 Substituted xanthine derivatives |
| 01/24/2013 | WO2013010964A1 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 01/24/2013 | CA2841552A1 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 01/23/2013 | EP2548558A1 Nitrogen-containing condensed heterocyclic as inhibitors of bruton's tyrosine kinase |
| 01/23/2013 | EP2547338A2 Imidazopyridine compounds, compositions and methods of use |
| 01/23/2013 | CN102887899A Novel chemical synthesis method for adenine |
| 01/23/2013 | CN101891741B New synthesis process of antiviral drug entecavir |
| 01/23/2013 | CN101801382B Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 01/23/2013 | CN101233134B 制备泛昔洛韦和其它嘌呤衍生物 Preparation of famciclovir and other purine derivatives |
| 01/22/2013 | US8357374 Conjugates of synthetic TLR agonists and uses therefor |
| 01/17/2013 | WO2013010136A2 Inhibitors of bruton's tyrosine kinase |
| 01/17/2013 | WO2013010102A2 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | US20130018026 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | US20130017171 Methods and compositions for treating hepatitis c virus |
| 01/17/2013 | CA2841080A1 Inhibitors of bruton's tyrosine kinase |
| 01/16/2013 | CN102884071A Novel artificial fluorescent bases |
| 01/16/2013 | CN102884063A Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
| 01/16/2013 | CN102875691A Method for synchronously preparing active substances from tea dregs |
| 01/16/2013 | CN102875554A Method for preparing 7-(2-hydroxypropyl) theophylline |
| 01/16/2013 | CN102875553A Preparation process for 8-chlorotheophylline and intermediate 7,8-dichlorotheophylline thereof |
| 01/15/2013 | US8354408 N-containing heterocyclic compounds |
| 01/15/2013 | CA2689092C Raf kinase modulators and methods of use |
| 01/10/2013 | WO2013004332A1 Substituted azaheterocycles for the treatment of cancer |
| 01/10/2013 | WO2012092484A3 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections |
| 01/10/2013 | US20130012526 Oxazole derivatives useful as modulators of faah |
| 01/10/2013 | US20130012515 Fused Bicyclic Pyridine and Pyrazine Derivatives as Kinase Inhibitors |
| 01/10/2013 | CA2840883A1 Substituted azaheterocycles for the treatment of cancer |
| 01/09/2013 | EP2543375A1 Pyrrolo-pyrimidine analogues as inhibitors of bruton's tyrosine kinase |
| 01/09/2013 | EP2542552A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | CN102869359A Imidazopyridine compounds, compositions and methods of use |
| 01/09/2013 | CN102863445A Novel method for synthesizing 9-substituted adenine compound |
| 01/09/2013 | CN102863444A Preparation method and intermediates of purine derivatives |
| 01/09/2013 | CN102276610B Method for preparing N7-guanine alkylate |